Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

被引:12
作者
Mohl, A. [1 ]
Boda, Z. [2 ]
Jager, R. [3 ]
Losonczy, H. [4 ]
Marosi, A. [5 ]
Masszi, T.
Nagy, E. [7 ]
Nemes, L. [8 ,9 ]
Obser, T. [10 ]
Oyen, F. [10 ]
Radvanyi, G. [11 ]
Schlammadinger, A. [2 ]
Szelessy, Z. S. [8 ,9 ]
Varkonyi, A.
Vezendy, K. [12 ]
Vilimi, B.
Schneppenheim, R. [10 ]
Bodo, I. [6 ]
机构
[1] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary
[2] Univ Debrecen, Dept Med, H-4012 Debrecen, Hungary
[3] Szombathely Blood Bank, Natl Blood Transfus Serv, Szombathely, Hungary
[4] Univ Pecs, Dept Med 1, Fac Med, Pecs, Hungary
[5] Heim Pal Childrens Hosp, Dept Haematol & Oncol, Budapest, Hungary
[6] St Istvan & St Laszlo Hosp Budapest, Haemostasis Div, Dept Haematol & Stem Cell Transplantat, H-1097 Budapest, Hungary
[7] Natl Inst Rheumatism & Physiotherapy, Immunol Lab, Budapest, Hungary
[8] Natl Haemophilia Ctr, Budapest, Hungary
[9] State Hlth Ctr, Haemostasis Dept, Budapest, Hungary
[10] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, Hamburg, Germany
[11] Semmelweis Hosp, Dept Med 2, Miskolc, Hungary
[12] Univ Szeged, Dept Transfus Med, Fac Med, Szeged, Hungary
关键词
genetic defect; type; 3; von Willebrand disease; SEVERE VONWILLEBRANDS DISEASE; FACTOR MESSENGER-RNA; CLINICAL MANIFESTATIONS; MOLECULAR-GENETICS; HEMOPHILIA-A; MUTATIONS; DEFECTS; SUBSTITUTION; EXPRESSION; FAMILIES;
D O I
10.1111/j.1538-7836.2011.04250.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 3 von Willebrand disease(VWD) is an autosomal recessive bleeding disorder, characterized by virtually undetectable plasma von Willebrand factor (VWF) and consequently reduced plasma factor VIII levels. Genetic mutations responsible for type 3 VWD are very heterogeneous, scattered throughout the VWF gene and show high variability among different populations. Methods: Twenty-five severe VWD patients were studied by direct sequencing of the 51 coding exons of the VWF gene. The total number of VWD type 3 families in Hungary is 24, of which 23 were investigated. Results: Fifteen novel mutations were identified in 31 alleles, five being nonsense mutations (p.Q1238X, p.Q1898X, p.Q1931X, p.S2505X and p.S2568X), four small deletions and insertions resulting in frame shifts (c.1992insC, c.3622delT, c.5315insGA and c.7333delG), one a large partial deletion (delExon1-3) of the 5'-region, four candidate missense mutations (p.C35R, p.R81G, p.C295S, p.C623T) and one a candidate splice site mutation (c.1730-10C > A). Six previously described mutations were detected in 17 alleles, including the repeatedly found c.2435delC, p.R1659X and p.R1853X. Only one patient developed alloantibodies to VWF, carrying a homozygous c.3622delT. Conclusion: We report the genetic background of the entire Hungarian type 3 VWD population. A large novel deletion, most probably due to a founder effect, seems to be unique to Hungarian type 3 VWD patients with high allele frequency. In contrast to previous reports, none of the five patients homozygous for the large partial deletion developed inhibitors to VWF. This discrepancy raises the possibility of selection bias in some of the reports.
引用
收藏
页码:945 / 952
页数:8
相关论文
共 39 条
[1]   Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients [J].
Baronciani, L ;
Cozzi, G ;
Canciani, MT ;
Peyvandi, F ;
Srivastava, A ;
Federici, AB ;
Mannucci, PM .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 30 (03) :264-270
[2]  
Baronciani L, 2000, THROMB HAEMOSTASIS, V84, P536
[3]   An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution [J].
Berber, E. ;
James, P. D. ;
Hough, C. ;
Lillicrap, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) :1672-1679
[4]   R924Q substitution encoded within exon 21 of the von Willebrand Factor gene related to mild bleeding phenotype [J].
Casais, Patricia ;
Carballo, Gonzalo A. ;
Woods, Adriana I. ;
Kempfer, Ana C. ;
Farias, Cristina E. ;
Grosso, Silvia H. ;
Lazzari, Maria A. .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (02) :228-230
[5]   An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type I von Willebrand disease [J].
Cumming, Anthony ;
Grundy, Pamela ;
Keeney, Stephen ;
Lester, William ;
Enayat, Said ;
Guilliatt, Andrea ;
Bowen, Derrick ;
Pasi, John ;
Keeling, David ;
Hill, Frank ;
Bolton-Maggs, Paula H. B. ;
Hay, Charles ;
Collins, Peter .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (05) :630-641
[6]  
EIKENBOOM JCJ, 1992, THROMB HAEMOSTASIS, V68, P448
[7]  
Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709
[8]   Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology [J].
Eikenboom, JCJ .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) :365-379
[9]   Clinical diagnosis of von Willebrand disease [J].
Federici, AB .
HAEMOPHILIA, 2004, 10 :169-176
[10]   Molecular genetics of type 2 von Willebrand disease [J].
Fressinaud, E ;
Mazurier, C ;
Meyer, D .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) :9-18